BIOTRICITY INCORPORATED (OTCMKTS:BTCY) Can’t Be More Risky. Short Interest Increased

September 17, 2017 - By Michael Collier

The stock of BIOTRICITY INCORPORATED (OTCMKTS:BTCY) registered an increase of 30.77% in short interest. BTCY’s total short interest was 1,700 shares in September as published by FINRA. Its up 30.77% from 1,300 shares, reported previously. With 2,300 shares average volume, it will take short sellers 1 days to cover their BTCY’s short positions.

It closed at $2.3 lastly. It is down 0.00% since September 17, 2016 and is . It has underperformed by 16.70% the S&P500.

Biotricity Inc is a Canada-based medical technology company. The company has market cap of $49.45 million. The Firm delivers remote biometric monitoring solutions, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. It currently has negative earnings. It offers bioflux, an Electrocardiogram monitoring system that enables physicians to diagnose cardiovascular diseases or coronary heart diseases, acts as an ambulatory monitor that detects arrhythmias, performs remote mobile cardiac telemetry diagnostic monitoring, and transmits ECG data via a built-in cellular radio in real time.

More notable recent Biotricity Inc (OTCMKTS:BTCY) news were published by: which released: “Biometric Monitoring Solutions Provider, Biotricity, Begins Trading on the OTC …” on February 03, 2016, also with their article: “biotricity Finalizes Partnership Expansion with the University of Calgary” published on October 25, 2016, published: “Renowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of Advisors” on November 01, 2016. More interesting news about Biotricity Inc (OTCMKTS:BTCY) were released by: and their article: “Biotricity changes year-end to move closer to qualifying to list on a National …” published on April 25, 2017 as well as‘s news article titled: “Biotricity Receives Ethics Approval to Investigate Mobile Wireless Fetal …” with publication date: June 20, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: